Literature DB >> 2226777

N-myc suppression and cell cycle arrest at G1 phase by prostaglandins.

N Marui1, T Sakai, N Hosokawa, M Yoshida, A Aoike, K Kawai, H Nishino, M Fukushima.   

Abstract

Effects of cyclopentenone prostaglandins, delta 12-prostaglandin (PG) J2 and PGA2 on the expression of N-myc in relation to the effects on cell cycle progression were investigated using human neuroblastoma cell line GOTO. Both PGs suppressed N-myc expression within several hours prior to inducing G1 arrest. The N-myc suppression with delta 12-PGJ2 was continued but with PGA2 it was gradually released, followed by the release of G1 arrest. These results suggest that delta 12-PGJ2 and PGA2 inhibit cell cycle progression in strong association with N-myc suppression and delta 12-PGJ2 is more potent and has a longer effect than PGA2.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2226777     DOI: 10.1016/0014-5793(90)81224-c

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

1.  Inhibition of G1 cyclin-dependent kinase activity during growth arrest of human breast carcinoma cells by prostaglandin A2.

Authors:  M Gorospe; Y Liu; Q Xu; F J Chrest; N J Holbrook
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

2.  Differential changes of adrenoceptor- and muscarinic receptor-linked prostacyclin synthesis by the aorta and urinary bladder of the diabetic rat.

Authors:  J Y Jeremy; C S Thompson; D P Mikhailidis
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

3.  Induction of HSP70 gene expression by the antiproliferative prostaglandin PGA2: a growth-dependent response mediated by activation of heat shock transcription factor.

Authors:  N J Holbrook; S G Carlson; A M Choi; J Fargnoli
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

Review 4.  Preclinical studies of antitumor prostaglandins by using human ovarian cancer cells.

Authors:  Y Kikuchi; T Kita; J Hirata; M Fukushima
Journal:  Cancer Metastasis Rev       Date:  1994-12       Impact factor: 9.264

5.  Regulation of C-myc protooncogene expression in osteoblastic cells by arachidonic acid metabolites: relationship to proliferation.

Authors:  W Ren; A J Kinniburgh; R Dziak
Journal:  Calcif Tissue Int       Date:  1992-04       Impact factor: 4.333

6.  The Role of PPAR Ligands in Controlling Growth-Related Gene Expression and their Interaction with Lipoperoxidation Products.

Authors:  Giuseppina Barrera; Cristina Toaldo; Stefania Pizzimenti; Angelo Cerbone; Piergiorgio Pettazzoni; Mario Umberto Dianzani; Carlo Ferretti
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

7.  Cell cycle-dependent modulation of promoter activities of RB and WAF1/Cip1 genes.

Authors:  T Matsumoto; N Ohtani-Fujita; Y Sowa; F Bai; T Nikaido; T Tamaki; T Sakai
Journal:  Jpn J Cancer Res       Date:  1998-06

8.  Combined COX-2/PPARγ Expression as Independent Negative Prognosticator for Vulvar Cancer Patients.

Authors:  Nadine Ansorge; Christian Dannecker; Udo Jeschke; Elisa Schmoeckel; Doris Mayr; Helene H Heidegger; Aurelia Vattai; Maximiliane Burgmann; Bastian Czogalla; Sven Mahner; Sophie Fuerst
Journal:  Diagnostics (Basel)       Date:  2021-03-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.